Project co-led by MecaTech and BioWin

Today, nuclear medicine PET (Positron Emission Tomography) also extends to neurology and cardiology. Nuclear cardiology uses noninvasive myocardial perfusion examination techniques to evaluate the pumping capacity of the heart and to detect the presence of ischemia or lesions. High quality imaging of PET scanners can provide a more accurate diagnosis, which can help define the best treatment. In order to make this technology more accessible in hospitals, IBA, Elysia and the universities of Liège and Louvain-la-Neuve have decided to pool their resources and their technological expertise to work on the next generation of radioisotope production solution for cardiac applications. This collaboration will greatly contribute to the global growth of cardiac PET in the years to come.

 

Consortium

Companies: IBA, Elysia Raytest

Univrersities: UCLouvain, ULiège

Contact:

Sébastien Linard de Guertechin: [email protected]

Website: https://iba-worldwide.com/